Israeli medical imaging vendor Elscint has won a contract to sellan MRI scanner to a Jordanian public hospital in a deal that isperhaps more important for its historic symbolism than its financialimpact. The system is the first sale of an Elscint MRI
Israeli medical imaging vendor Elscint has won a contract to sellan MRI scanner to a Jordanian public hospital in a deal that isperhaps more important for its historic symbolism than its financialimpact. The system is the first sale of an Elscint MRI scannerto an Arab country, according to Jonathan Adereth, president ofHaifa-based Elscint.
Israel and Jordan signed a peace agreement in 1994 that endedyears of hostility between the countries. The agreement also openedthe Jordanian market to Elscint's products, and in January thecompany won a deal from the Jordanian government to sell a 2-teslaPrestige scanner to Hospital El Bashir in Amman, beating out bidsfrom GE and Siemens.
Although the Arab market probably will not be a large one forElscint, the agreement is a breakthrough that represents the warmingpolitical and business ties between the nations.
"It was something more than just getting an order,"Adereth said. "It was a milestone on the march for establishingreal peace and relations between the countries."
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.